Figure 1.
Overview on the relevance and regulatory value of in vivo studies for biosimilar candidates. *) specific studies like carcinogenicity, reproductive toxicity etc. are not required for biosimilars.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.